LAUSR

Atopic dermatitis (AD) is one of the most common inflammatory skin diseases in the developed world, affecting 1–3% of the adult population in Europe. This inflammatory disease can have a marked impact on affected individuals, leading to significant impairment in physical wellbeing and quality of life (QoL). The aim of this study was to investigate the psychosocial impact and financial burden of AD on patients in Ireland. To increase our understanding of the psychosocial and financial aspects of AD disease burden in the Irish population, an online survey was designed. The survey was launched by the Irish Skin Foundation, and included questions focusing on disease severity, disease control, psychosocial impact, interrupted sleep, missed work and school days, and financial cost. The survey showed that the impact of AD on QoL was profound. The survey demonstrated that 85% of adults described interrupted sleep, 70% reported social anxiety, 65% avoid exercise and sports, 52% avoid social activities, 52% avoid sexual intimacy and 43% feel they are depressed as a result of their AD. Approximately one‐quarter of those surveyed can spend up to €2300 annually on over‐the‐counter, prescription and alternative treatments. This study has shown the significant impact AD has on patients living in Ireland. It also highlights that out‐of‐pocket costs for patients is higher compared with previous studies across European countries.